Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aerocrine has reported the filing with the District Court of Dusseldorf, of a complaint and motion to prevent Medisoft, from marketing and selling its exhaled Nitric Oxide analyser in Germany.
Subscribe to our email newsletter
Medisoft has recently begun marketing and selling the Hypair exhaled Nitric Oxide (NO) analyser in Germany. Aerocrine claims the Medisoft Hypair Analyser infringes four of Aerocrine’s European patents. The claim seeks both an injunction and damages.
Paul de Potocki, CEO of Aerocrine, said: “Aerocrine’s view is that Medisoft’s product Hypair uses Aerocrine’s proprietary technology. We welcome other companies to join Aerocrine in bringing the benefits of inflammation monitoring to patients and care providers, but we will defend our company’s patents resolutely.”